Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: Results of the open-label Extension Study of the FLEXX Trial

Osteoarthritis and Cartilage

Volumn 19, Issue 10, 2011, Pages 1169-1175

  Altman, R D ^a   Rosen, J E ^b,c,d   Bloch, D A ^e   Hatoum, H T ^f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

^e STANFORD UNIVERSITY   (United States)

^f Hind T Hatoum and Company   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bioengineered; FLEXX Trial; Intra articular hyaluronate; Osteoarthritis

Indexed keywords

BIOENGINEERED HYALURONIC ACID; EUFLEXXA; HYALURONIC ACID; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTHRALGIA; ARTICLE; BACKACHE; BIOENGINEERING; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HUMAN; HYPERSENSITIVITY; HYPERTENSION; INJECTION SITE PAIN; INJECTION SITE SWELLING; JOINT SWELLING; KNEE INJURY; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; RHINOPHARYNGITIS; SCORING SYSTEM; SHORT FORM 36; SINUSITIS; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VISUAL ANALOG SCALE;

ADJUVANTS, IMMUNOLOGIC; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; TREATMENT OUTCOME; WALKING;

EID: 81155159744     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.07.001     Document Type: Article

References (19)

1. Altman R.D., Rosen J.E., Bloch D.A., Hatoum H.T., Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum 2009, 39:1-9.
2. Jüni P., Reichenbach S., Trelle S., Tschannen B., Wandel S., Jordi B., et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007, 56:3610-3619.
3. Petrella R.J., Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol 2006, 33:951-956.
4. Altman R.D., Akermark C., Beaulieu A.D., Schnitzer T., Durolane International Study Group Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004, 12:642-649.
5. Tamir E., Robinson D., Koren R., Agar G., Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001, 19:265-270.
6. Altman R.D., Moskowitz R., Hyalgan Study Group Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998, 25:2203-2212.
7. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162.
8. EUFLEXXA ®(1% sodium hyaluronate) United States Prescribing Information 2009, Ferring Pharmaceuticals Inc, Available at:. http://www.euflexxa.com/files/euflexxa_physician.pdf.
9. Kotz R., Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999, 28(Suppl):5-7.
10. Petrella R.J., Cogliano A., Decaria J. Comparison of avian and nonavian hyaluronic acid in osteoarthritis of the knee. Orthop Res Rev 2010, 2:5-9.
11. Jubb R.W., Piva S., Beinat L., Dacre J., Gishen P. A one-year, randomized, placebo (saline) controlled clinical trial of 500-730 KDA sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003, 57:467-474.
12. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004, 12:389-399.
13. Ware J.E., Kosinski M., Bjorner J., Turner-Bowker D., Gandek B., Maruish M. User's Manual for the SF-36v2 Health Survey 2007, Quality Metric Incorporated, Lincoln, RI. 2nd edn.
14. Navarro Sarabia F, Toyos Saenz de Miera J, Colonel Granado P, Hernandez Cruz B, Gimeno del Sol M. Long-term intra-articular injections of hyaluronic acid (Adant) are effective and well tolerated. AMELIA study results. Presented at PANLAR, 2010.
15. Petrella R.J. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 2005, 84:278-283.
16. Listrat V., Ayral X., Patarnello F., Bonvarlet J.P., Simonnet J., Armor B., et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan®) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997, 5:153-160.
17. Scali J.J. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. Eur J Rheumatol Inflamm 1995, 15:57-62.
18. Reichenbach S., Blank S., Rutjes A.W., Shang A., King E.A., Dieppe P.A., et al. Hylan versus hyaluronic acid for viscosupplementation in knee osteoarthritis: meta-analysis of randomised controlled trials. Arthritis Rheum 2007, 57:1410-1418.
19. Wu Y.T., Makuch R.W. Sample size for post-marketing safety studies based on historical controls. Pharmacoepidemiol Drug Saf 2010, 19:869-875.